Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ages Industri B | AGESB | 27. dec 2024 | 68.40 | +0.89 |
Agtira B | AGTIRAB | 27. dec 2024 | 1.42 | -8.71 |
AIK Fotboll AB | AIKB | 27. dec 2024 | 1.67 | +0.30 |
Aino Health | AINO | 27. dec 2024 | 0.24 | -20.00 |
Aixia B | AIXIAB | 27. dec 2024 | 130.00 | +1.56 |
Akelius Residential Property D | AKELD | 27. dec 2024 | 1.64 | +0.12 |
Alcadon Group | ALCA | 27. dec 2024 | 29.00 | +2.11 |
Alfa Laval | ALFA | 27. dec 2024 | 464.70 | +0.58 |
Alimak Group | ALIG | 27. dec 2024 | 113.40 | +0.35 |
Alleima AB | ALLEI | 27. dec 2024 | 75.20 | +1.01 |
Alligator Bioscience | ATORX | 27. dec 2024 | 0.25 | -3.61 |
Alligo B | ALLIGOB | 27. dec 2024 | 124.20 | -1.27 |
ALM Equity | ALM | 27. dec 2024 | 157.00 | -0.63 |
ALM Equity Pref | ALMPREF | 27. dec 2024 | 84.10 | +0.72 |
Alpcot Holding B | ALPCOTB | 27. dec 2024 | 0.69 | +15.00 |
Alteco | ALTE | 27. dec 2024 | 0.25 | +8.70 |
AlzeCure Pharma | ALZCUR | 27. dec 2024 | 1.17 | -1.68 |
Alzinova | ALZ | 27. dec 2024 | 3.32 | +0.61 |
Ambea | AMBEA | 27. dec 2024 | 95.85 | -0.73 |
Amhult 2 B | AMH2B | 27. dec 2024 | 57.50 | -0.86 |
Amido | AMIDO | 27. dec 2024 | 1.77 | 0.00 |
Angler Gaming | ANGL | 27. dec 2024 | 4.62 | +1.32 |
Annehem Fastigheter B | ANNEB | 27. dec 2024 | 15.70 | +0.96 |
Annexin Pharmaceuticals | ANNX | 27. dec 2024 | 0.41 | -9.09 |
Anoto Group | ANOT | 27. dec 2024 | 0.11 | +1.82 |
ANTCO. Investment Group | ANTCOB | 27. dec 2024 | 0.13 | +2.31 |
Apotea | APOTEA | 27. dec 2024 | 81.25 | 0.00 |
Appspotr | APTR | 27. dec 2024 | 0.12 | +4.55 |
Aprendere Skolor | APRNDR | 27. dec 2024 | 11.50 | +1.77 |
Aptahem | APTA | 27. dec 2024 | 1.45 | +26.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.